All Relations between Alzheimer Disease and Neurodegenerative Diseases

Reference Sentence Publish Date Extraction Date Species
Hu Zhang, Jiling Liang, Ning Che. The Potential Role of miRNA-Regulated Autophagy in Alzheimer's Disease. International journal of molecular sciences vol 23 issue 14 2022 35887134 as a neurodegenerative disease, alzheimer's disease (ad) shows a higher incidence during the aging process, mainly revealing the characteristics of a significant decrease in cognition, uncontrolled emotion, and reduced learning and memory capacity, even leading to death. 2022-07-27 2022-08-08 Not clear
Alexandria B Marciante, John Howard, Mia N Kelly, Juan Santiago Moreno, Latoya L Allen, Elisa J Gonzalez-Rothi, Gordon S Mitchel. Dose-dependent Phosphorylation of Endogenous Tau by Intermittent Hypoxia in Rat Brain. Journal of applied physiology (Bethesda, Md. : 1985) vol issue 2022 35861520 sleep apnea is comorbid in >50% of patients with alzheimer's disease-a progressive, neurodegenerative disease associated with brain amyloid and chronic tau dysregulation (pathology). 2022-07-21 2022-07-25 Not clear
Cong Li. The Role of Mesenchymal Stem Cells in Regulating Astrocytes-Related Synapse Dysfunction in Early Alzheimer's Disease. Frontiers in neuroscience vol 16 issue 2022 35801178 alzheimer's disease (ad), a neurodegenerative disease, is characterized by the presence of extracellular amyloid-\xce\xb2 (a\xce\xb2) aggregates and intracellular neurofibrillary tangles formed by hyperphosphorylated tau as pathological features and the cognitive decline as main clinical features. 2022-07-08 2022-07-11 Not clear
S Tok, H Maurin, C Delay, D Crauwels, N V Manyakov, W Van Der Elst, D Moechars, W H I M Drinkenbur. Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease. Scientific reports vol 12 issue 1 2022 35546164 alzheimer's disease (ad) is a neurodegenerative disease characterized by two main pathological hallmarks: amyloid plaques and intracellular tau neurofibrillary tangles. 2022-05-13 2022-06-13 Not clear
Yongle Cai, Jingliu Liu, Bin Wang, Miao Sun, Hao Yan. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets. Frontiers in immunology vol 13 issue 2022 35558075 alzheimer's disease (ad) is the most prevalent neurodegenerative disease worldwide, characterized by progressive neuron degeneration or loss due to excessive accumulation of \xce\xb2-amyloid (a\xce\xb2) peptides, formation of neurofibrillary tangles (nfts), and hyperphosphorylated tau. 2022-05-13 2022-06-13 Not clear
Joubin Jebelli, Michael C Hamper, Danielle Van Quelef, Davian Caraballo, James Hartmann, James Kumi-Diak. The Potential Therapeutic Effects of Low-Dose Ionizing Radiation in Alzheimer's Disease. Cureus vol 14 issue 3 2022 35371871 alzheimer's is classified as a progressive, debilitating neurodegenerative disease that results in disturbances to a patient's higher executive function, memory, language, and visuospatial orientation. 2022-04-04 2022-04-14 Not clear
Filipa Gouveia, Antoni Camins, Miren Ettcheto, Joana Bicker, Am\\xc3\\xadlcar Falc\\xc3\\xa3o, M Teresa Cruz, Ana Fortun. Targeting Brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: past, present and future. Ageing research reviews vol issue 2022 35346852 alzheimer's disease (ad) is a well-known neurodegenerative disease characterized by the presence of two main hallmarks - tau hyperphosphorylation and a\xce\xb2 deposits. 2022-03-29 2022-04-14 Not clear
Min Cao, Jing Liu, Xiaomin Zhang, Tingting Yang, Yaqi Wang, Yuli Hou, Qiao Song, Yuting Cui, Yifei Wang, Peichang Wan. ABI3 Is a Novel Early Biomarker of Alzheimer's Disease. Journal of Alzheimer's disease : JAD vol issue 2022 35275543 the abi3 gene has been suggested to be an important regulator of microglia during alzheimer's disease (ad), but the diagnostic power of abi3 in neurodegenerative disease has rarely been reported. 2022-03-11 2022-04-14 Not clear
Thibaut Gauvrit, Hamza Benderradji, Luc Bu\\xc3\\xa9e, David Blum, Didier Viea. Early-Life Environment Influence on Late-Onset Alzheimer's Disease. Frontiers in cell and developmental biology vol 10 issue 2022 35252195 alzheimer disease (ad) which is the most prevalent neurodegenerative disease is mostly sporadic and primarily characterized by cognitive deficits and neuropathological lesions such as amyloid -\xce\xb2 (a\xce\xb2) plaques and neurofibrillary tangles composed of hyper- and/or abnormally phosphorylated tau protein. 2022-03-08 2022-03-09 Not clear
Thibaut Gauvrit, Hamza Benderradji, Luc Bu\\xc3\\xa9e, David Blum, Didier Viea. Early-Life Environment Influence on Late-Onset Alzheimer's Disease. Frontiers in cell and developmental biology vol 10 issue 2022 35252195 alzheimer disease (ad) which is the most prevalent neurodegenerative disease is mostly sporadic and primarily characterized by cognitive deficits and neuropathological lesions such as amyloid -\xce\xb2 (a\xce\xb2) plaques and neurofibrillary tangles composed of hyper- and/or abnormally phosphorylated tau protein. 2022-03-07 2022-03-09 Not clear
Baofeng Gong, Wenbo Ji, Xiaohan Chen, Peng Li, Wenbin Cheng, Yuchen Zhao, Bin He, Jianhua Zhuang, Jie Gao, You Yi. Recent Advancements in Strategies for Abnormal Protein Clearance in Alzheimer's Disease. Mini reviews in medicinal chemistry vol issue 2022 35156576 alzheimer's disease (ad) is a intricate neurodegenerative disease with chronic and progressive development whose typical neuropathological features encompasses senile plaques and neurofibrillary tangles respectively formed by the extracellular deposition of amyloid-beta (a\xce\xb2) and the intracellular accumulation of hyperphosphorylated tau protein in the brain, particularly in limbic and cortical regions. 2022-02-14 2022-02-17 Not clear
Kemeng Pan, Song Chen, Yue Wang, Wenbing Yao, Xiangdong Ga. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease. Neuropharmacology vol 196 issue 2021 34153312 alzheimer's disease (ad) is a neurodegenerative disease, the main pathological features include deposition of neurofibrillary tangles composed of the abnormally hyperphosphorylated tau protein and plaques deposition composed of \xce\xb2-amyloid (a\xce\xb2) peptide. 2022-02-02 2022-01-13 Not clear
Dalia A Mandour, M A Bendary, Amira E Alseme. Histological and imunohistochemical alterations of hippocampus and prefrontal cortex in a rat model of Alzheimer like-disease with a preferential role of the flavonoid \"hesperidin\". Journal of molecular histology vol 52 issue 5 2021 34170456 alzheimer's disease (ad) is a chronic age-related neurodegenerative disease characterized by degeneration of the central cholinergic neurons, inflammation and oxidative stress in the basal forebrain, prefrontal cortex and hippocampus. 2022-01-27 2022-01-13 Not clear
Martin J Dahl, Mara Mather, Markus Werkle-Bergner, Briana L Kennedy, Samuel Guzman, Kyle Hurth, Carol A Miller, Yuchuan Qiao, Yonggang Shi, Helena C Chui, John M Ringma. Locus coeruleus integrity is related to tau burden and memory loss in autosomal-dominant Alzheimer's disease. Neurobiology of aging vol 112 issue 2022 35045380 our findings link lc degeneration to tau burden and memory in alzheimer's, and highlight a role of the noradrenergic system in this neurodegenerative disease. 2022-01-19 2022-01-27 Not clear
Hongxia Yu, Jianhong Shi, Yiyou Lin, Yehui Zhang, Qihang Luo, Suo Huang, Sichen Wang, Jiale Wei, Junhao Huang, Changyu Li, Liting J. Icariin Ameliorates Alzheimer's Disease Pathology by Alleviating Myelin Injury in 3\\xe2\\x80\\x89\\xc3\\x97\\xe2\\x80\\x89Tg-AD Mice. Neurochemical research vol issue 2022 35037164 alzheimer's disease (ad) is a neurodegenerative disease characterized by excessive deposition of \xce\xb2 amyloid (a\xce\xb2), hyperphosphorylation of tau protein, and neuronal cell death. 2022-01-17 2022-01-27 Not clear
Smita Eknath Desale, Hariharakrishnan Chidambaram, Subashchandrabose Chinnathamb. G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-\\xce\\xb2 in Alzheimer's disease. Molecular biomedicine vol 2 issue 1 2022 35006431 alzheimer's disease is a progressive neurodegenerative disease characterized by the presence of amyloid-\xce\xb2 plaques in the extracellular environment and aggregates of tau protein that forms neurofibrillary tangles (nfts) in neuronal cells. 2022-01-10 2022-01-13 Not clear
Ni-Ni Chiang, Te-Hsien Lin, Yu-Shan Teng, Ying-Chieh Sun, Kuo-Hsuan Chang, Chung-Yin Lin, Hsiu Mei Hsieh-Li, Ming-Tsan Su, Chiung-Mei Chen, Guey-Jen Lee-Che. Flavones 7,8-DHF, Quercetin, and Apigenin Against Tau Toxicity Frontiers in aging neuroscience vol 13 issue 2022 34975454 flavones 7,8-dhf, quercetin, and apigenin against tau toxicity alzheimer's disease (ad) is a progressive neurodegenerative disease with memory loss and cognitive decline. 2022-01-03 2022-01-13 Not clear
Viviana Soto-Mercado, Miguel Mendivil-Perez, Carlos Velez-Pardo, Marlene Jimenez-Del-Ri. (-)-Epigallocatechin-3-Gallate Diminishes Intra-and Extracellular Amyloid-Induced Cytotoxic Effects on Cholinergic-like Neurons from Familial Alzheimer's Disease PSEN1 E280A. Biomolecules vol 11 issue 12 2021 34944489 alzheimer's disease (ad) is a complex neurodegenerative disease characterized by functional disruption, death of cholinergic neurons (chns) because of intracellular and extracellular a\xce\xb2 aggregates, and hyperphosphorylation of protein tau (p-tau). 2021-12-24 2022-01-13 Not clear
Giambattista Marotta, Filippo Basagni, Michela Rosini, Anna Minarin. Role of Fyn Kinase Inhibitors in Switching Neuroinflammatory Pathways. Current medicinal chemistry vol issue 2021 34939537 based on these premises, fyn emerges as an attractive target in cancer and neurodegenerative disease therapy, particularly alzheimer disease (ad), based on its activation by a\xce\xb2 via cellular prion protein and its interaction with tau protein. 2021-12-23 2022-01-13 Not clear
Pei-Pei Guan, Long-Long Cao, Yi Yang, Pu Wan. Calcium Ions Aggravate Alzheimer's Disease Through the Aberrant Activation of Neuronal Networks, Leading to Synaptic and Cognitive Deficits. Frontiers in molecular neuroscience vol 14 issue 2021 34924952 alzheimer's disease (ad) is a neurodegenerative disease that is characterized by the production and deposition of \xce\xb2-amyloid protein (a\xce\xb2) and hyperphosphorylated tau, leading to the formation of \xce\xb2-amyloid plaques (aps) and neurofibrillary tangles (nfts). 2021-12-20 2022-01-13 Not clear
Page: 
1   2   3   4   5   6   7   8   9   10